Project Grant HT94252411041
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$626K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90024, USA
Similar Awards
The University of California, Los Angeles (UCLA), through its Office of Research Administration, was awarded a $1,366,628 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the role of oxidative mitochondrial metabolism in resistance to androgen receptor inhibition from July 1, 2023 to June 30, 2026. As the prime awardee, UCLA will leverage its research facilities and faculty...
The University of California, Los Angeles (UCLA), under its Office of Research Administration, received a $157,473 Project Grant award from the Defense Health Agency (DHA) on May 1, 2024 to conduct research for the "TESTING UCHL1 AS A NEW MINIMALLY INVASIVE BIOMARKER AND THERAPEUTIC TARGET FOR NEUROENDOCRINE PROSTATE CANCER" project. This award is funded through the DHA's Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research...
The University of California, Los Angeles will receive $1,169,966 under a three-year Project Grant from the Department of the Army Medical Command titled "The Role of Genomic Diversity in Clinically High-Risk Prostate Cancer." The grant is part of the Military Medical Research and Development program administered by the Department of Defense and aims to transform military and public health through innovative medical research. Specifically, UCLA will investigate the role of genomic...
The University of California, Los Angeles (UCLA), through its Office of Research Administration, has been awarded a $2,351,564.00 Project Grant from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development. This four-year grant, with a period of performance from August 15, 2023 to August 14, 2027, will support research targeting the EGFR signaling network in glioblastoma. As the prime grantee, UCLA will leverage its research facilities, faculty...
This federal Project Grant award, totaling $472,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of California, Los Angeles (UCLA) to investigate targeting TROP2-mediated ferroptosis as a new therapy for advanced prostate cancer. The research project aims to transform healthcare for military service members and the broader public by exploring innovative approaches to cancer treatment....
The Defense Health Agency awarded a $468,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research developing new therapeutic strategies to target TROP2 in aggressive prostate cancer. The two-year award beginning March 15, 2023 will fund research efforts to investigate medical solutions for prostate cancer on the battlefield and transform health care for service members and the public...
The Department of the Army Medical Command awarded a $1,559,475 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support integrated meta-analysis of prostate cancer genomes from April 15, 2022 to April 15, 2025. Through the grant funding, UCLA will conduct research to transform health care for service members and the public by investigating medical solutions for the battlefield....
The University of California, Los Angeles will receive $2.34 million under a Project Grant award from the Department of the Army Medical Command to target N-cadherin for inhibition of enzalutamide resistance and emergence of neuroendocrine prostate cancer. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve military and public health through innovative medical solutions for battlefield care and other...
The Defense Health Agency has awarded a $893,000 Project Grant to the University of California, Los Angeles (UCLA) - Office of Research Administration to conduct research under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, effective August 15, 2023 through August 14, 2027, will support UCLA's efforts to investigate the EGFR signaling network in glioblastoma, an aggressive form of brain cancer. As the prime grantee, UCLA will leverage its research...
The University of California, Los Angeles (UCLA) was awarded a $662,086 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from May 1, 2022 to April 30, 2025 to investigate NUDT5 as a novel target for ovarian cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goal of transforming health care for...